Dr. Reddy's Laboratories Limited

IncreasedQuarterly

DRREDDYPharmaceuticalsMarket Cap₹98K Cr

Stake

4.01% → 4.41%

ICICI Prudential Mutual Fund

Mutual Fund

The move

ICICI Prudential Mutual Fund increased its stake in Dr. Reddy's Laboratories from 4.01% to 4.41%, buying 6,838,548 additional shares.

About Dr. Reddy's Laboratories Limited

Visit stock

A leading India-based pharmaceutical company, Dr Reddy's Laboratories manufactures and distributes Active Pharmaceutical Ingredients, generic medicines, biosimilars, and differentiated formulations across multiple therapeutic areas. The company operates custom pharmaceutical services and serves patients in markets worldwide. Its integrated operations span drug discovery, development, manufacturing, and commercialization of innovative and generic pharmaceuticals for diverse healthcare needs.

About ICICI Prudential Mutual Fund

Visit investor

India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.

Get the next move the moment it happens.

Follow ICICI Prudential Mutual Fund and Dr. Reddy's Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Dr. Reddy's Laboratories Limited shareholders ICICI Prudential Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Dr. Reddy's Laboratories Limited

ICICI Prudential Mutual FundIncreased

ICICI Prudential Mutual Fund raised its stake in Dr. Reddy's Laboratories from 4.92% to 5.01%, buying 7,12,884 shares in an open market transaction and crossing the 5% disclosure threshold.

12 Aug 2026

Nippon India Mutual FundDecreased

Nippon India Mutual Fund decreased its stake in Dr. Reddy's Laboratories by selling 3,705,462 shares. The fund's holding changed from 15,130,303 shares to 11,424,841 shares.